NVAX

Novavax, Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-02-26

Figures on this page computed 2026-11-08 12:41 UTC

Last close

10.65USD

Market data, 2026-11-04

Except where said otherwise: 10-K for 2025, filed 2026-02-26

4.0xP/E
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001000694-26-000007
Reported in
USD
- computed
- 10-K for 2025, filed 2026-02-26
The filing itself
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001000694-26-000007
Reported in
USD
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
- 10-Q for 2025, filed 2026-08-06
- 10-K for 2025, filed 2026-02-26
- 10-Q for 2025, filed 2026-08-06
The filing itself
39.2%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001000694-26-000007
Reported in
USD
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
The filing itself
-22.3%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001000694-26-000007
Reported in
USD
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
The filing itself
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001000694-26-000007
Reported in
USD
- 10-K for 2025, filed 2026-02-26
- 10-Q for 2025, filed 2026-08-06
The filing itself
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Safety is the furthest below its sector's middle: 0.52 against 0.53 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

1.73x

-1.13x

1.13x

1.00x

0.25x

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Filed2025

Market data2026-11-04

Each against its own average

5 of 5 read

Except where said otherwise: 10-K for 2025, filed 2026-02-26

Sales1.73x
Its own average over 10 years, 649.3M.
Profit-1.13x
Its own average over 10 years, -389.3M.
Free cash flow1.13x
Its own average over 10 years, -220.5M.
Debt1.00x
Its own average over 1 year, 278.0M.
Price0.25x
Its own average over 11 years, 42. Market data, 2026-11-04

Profit is furthest from its own average, at -1.13 times.

Sales is 1.73 times its own 10-year average; Profit is -1.13 times its own 10-year average; Free cash flow is 1.13 times its own 10-year average; Debt is 1.00 times its own 1-year average; Price is 0.25 times its own 11-year average.

Every figure in this lens

Except where said otherwise: 10-K for 2025, filed 2026-02-26

Sales against its own 10-year average1.73
Source
filed
Statement
income
Fiscal year
2025
Accession
0001000694-26-000007
Reported in
USD
The filing itself
Profit against its own 10-year average-1.13
Source
filed
Statement
income
Fiscal year
2025
Accession
0001000694-26-000007
Reported in
USD
The filing itself
Free cash flow against its own 10-year average1.13
Source
filed
Statement
income
Fiscal year
2025
Accession
0001000694-26-000007
Reported in
USD
The filing itself
Debt against its own 1-year average1.00
Source
filed
Statement
income
Fiscal year
2025
Accession
0001000694-26-000007
Reported in
USD
The filing itself
Price against its own 11-year average0.25Market data, 2026-11-04
Source
market
Taken on
2026-11-04
Reported in
USD